» Authors » Mikeljon P Nikolich

Mikeljon P Nikolich

Explore the profile of Mikeljon P Nikolich including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 55
Citations 675
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Peters T, Kirillina O, Georges M, Margulieux K, Burke K, Mzhavia N, et al.
Microbiol Resour Announc . 2025 Feb; 14(3):e0101024. PMID: 39912636
We describe the genomes of three lytic phages of the genus . The genomes of phages vB_Pae4841-AFR43, vB_Pae10145-KEN1, and vB_Pae9718-KEN10 consist of 43,426, 43,406, and 43,118 bp, with 62.4%, 62.3%,...
2.
Aslam S, Roach D, Nikolich M, Biswas B, Schooley R, Bishop-Lilly K, et al.
Antimicrob Agents Chemother . 2025 Jan; 69(2):e0180024. PMID: 39772863
No abstract available.
3.
Peters T, Urick C, Georges M, Burke K, Kirillina O, Mzhavia N, et al.
Microbiol Resour Announc . 2024 Nov; 13(12):e0105624. PMID: 39576091
We describe the genomes of five lytic myophages, therapeutic candidates, that belong to the family and genus . The genomes ranged from 165,574 to 169,768 bp, with ca. 40% GC...
4.
Musila L, Bird J, Margulieux K, Kigen C, Mzhavia N, Filippov A, et al.
Microbiol Resour Announc . 2024 Oct; 13(11):e0068424. PMID: 39377596
The genomes of three bacteriophages isolated in Kenya are described. The genomes of phages vB_PaePAO1-KEN19, vB_Pae3705-KEN49, and vB_Pae10145-KEN51, respectively, had lengths of 278,921, 280,231, and 280,173 bp, with 36.93%, 36.84%,...
5.
Aslam S, Roach D, Nikolich M, Biswas B, Schooley R, Lilly-Bishop K, et al.
Antimicrob Agents Chemother . 2024 Mar; 68(4):e0172823. PMID: 38470133
Left ventricular assist devices (LVAD) are increasingly used for management of heart failure; infection remains a frequent complication. Phage therapy has been successful in a variety of antibiotic refractory infections...
6.
Burke K, Urick C, Mzhavia N, Nikolich M, Filippov A
Int J Mol Sci . 2024 Feb; 25(3). PMID: 38338703
Phage therapeutics offer a potentially powerful approach for combating multidrug-resistant bacterial infections. However, to be effective, phage therapy must overcome existing and developing phage resistance. While phage cocktails can reduce...
7.
Bird J, Burke K, Urick C, Braverman J, Mzhavia N, Ellison D, et al.
Microbiol Resour Announc . 2023 Nov; 13(1):e0095423. PMID: 38032190
We describe the genome of a lytic phage EKq1 isolated on , with activity against . EKq1 is an unclassified representative of the class Caudoviricetes, similar to phages VLCpiS8c, phiKp_7-2,...
8.
Ergunay K, Bourke B, Reinbold-Wasson D, Nikolich M, Nelson S, Caicedo-Quiroga L, et al.
Sci Rep . 2023 Nov; 13(1):19824. PMID: 37963929
We analysed both pooled and individual tick samples collected from four countries in Eastern Europe and the Black Sea region, using metagenome-based nanopore sequencing (NS) and targeted amplification. Initially, 1337...
9.
Parmar K, Komarow L, Ellison D, Filippov A, Nikolich M, Fackler J, et al.
J Clin Microbiol . 2023 Nov; 61(12):e0061423. PMID: 37962552
Standardized approaches to phage susceptibility testing (PST) are essential to inform selection of phages for study in patients with bacterial infections. There is no reference standard for assessing bacterial susceptibility...
10.
Margulieux K, Bird J, Kevorkian R, Ellison D, Nikolich M, Mzhavia N, et al.
Microbiol Resour Announc . 2023 Aug; 12(9):e0034123. PMID: 37607055
We describe the genome of a lytic phage EAb13 isolated from sewage, with broad activity against multidrug-resistant . EAb13 is an unclassified siphovirus. Its genome consists of 82,411 bp, with...